You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page

No matches

Rhinology

On demand events

Global CRSwNP Awareness Day 2024

Explore resources on the importance of partnering with patients to empower them to take an active role in their care.

MD, PhD

Joaquim Mullol +3 more

Description

April 24 is Global CRSwNP Awareness Day. The 2024 Global CRSwNP Awareness Day theme is "The Empowered Patient." For patients with CRSwNP, chronic symptoms are the primary drivers of decreases in health-related quality of life. Involving patients in their own care is 1 of the 4 cardinal principles of precision medicine and is key to improving their health-related quality of life.

The ADVENT program is committed to providing high-quality medical education that enables you to play a role in empowering patients.

Learn more about partnering with patients to achieve meaningful outcomes in CRSwNP at ADVENTprogram.com.

About these experts

Rhinology

MD, PhD

Joaquim Mullol

Director of the Rhinology Unit & Smell Clinic, Department of Otorhinolaryngology | Hospital Clinic, Barcelona, Spain; Professor of Research and Head of the Laboratory of Clinical and Experimental Respiratory Immunoallergy | August Pi i Sunyer Biomedical Research Institute, Barcelona, Spain | Head of Research Group at Biomedical Research Network on Respiratory Diseases (CIBERES) | Carlos III Institute of Health, Barcelona, Spain

Rhinology

Stella Lee

Chief of Rhinology at Brigham and Women’s Hospital | Harvard Medical School, Boston, United States

Rhinology

MD, PhD

Wytske Fokkens

Professor in the Department of Otorhinolaryngology | Academic Medical Center, Amsterdam, Netherlands; Director | European Forum for Research and Education in Allergy and Airway Diseases (EUFOREA)

Rhinology

MD, PhD

Peter Hellings

Professor and Clinic Head of the Department of Otorhinolaryngology | University Hospitals of Leuven, Belgium

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region